TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
RGNX

Regenxbio Inc

Healthcare · Biotechnology

8.20$ +2.9% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Regenxbio Inc (RGNX): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/05/2026.

Next report 11/05/2026
Last report 08/06/2026
Earnings surprise by quarter (%)
Q3 23 · 7.2 % 23 Q4 23 · -12.6 % 23 Q1 24 · -6.4 % 24 Q2 24 · 19.9 % 24 Q3 24 · -6.4 % 24 Q4 24 · 6.9 % 24 Q1 25 · -75.5 % 25 Q2 25 · -22.1 % 25 Q3 25 · 7.7 % 25 Q4 25 · -80.7 % 25 Q1 26 · -22.0 % 26 Q2 26 · 258.3 % 26

EPS estimate beaten

Full history 20 of 44 quarters (45%)
Last 16 quarters 5 of 16 quarters (31%)

Earnings Call Transcripts

Search all transcripts →

  • 05/14/2026 Earnings Call Q1 2026 Open →
  • 03/05/2026 Earnings Call Q4 2025 Open →
  • 11/06/2025 Earnings Call Q3 2025 Open →

News on This Stock

  • 08/25/2026 REGENXBIO Inc. (RGNX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/24/2026 REGENXBIO Inc. (RGNX): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/06/2026 REGENXBIO Inc. (RGNX): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/20/2026 REGENXBIO Inc. (RGNX): Other Events; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?